I
nterleukin-2 is a potent growth factor for T cells in vitro (1) . As such, a similar growth-promoting function for IL-2 was expected in vivo. However, mice with targeted disruptions of the IL-2 or IL-2R genes display a severe lymphoproliferative disorder characterized by splenomegaly, lymphadenopathy, and anemia (2) (3) (4) (5) . This lymphoproliferative disorder is present even in mice that are maintained under gnotobiotic conditions (6) , suggesting that IL-2 is essential in down-regulating responses to self Ags. IL-2 may function by programming autoreactive cells to undergo activation-induced cell death (7) (8) (9) (10) , by maintaining regulatory T cells (11) (12) (13) (14) , or by regulating thymic selection (15) (16) (17) (18) .
The role of IL-2 in the regulation of immune responses to infectious agents in vivo remains unknown. Few studies have examined this issue, although a number of systems have been used to test the role of IL-2 in the growth and deletion of CD4 and CD8 T cells in response to model Ags or superantigens. Overall, the available data suggest that for CD4 T cells, IL-2 is not an essential growth factor in vivo but may play a role in inducing apoptosis in responding CD4 T cells (10, 19 -22) , although the latter is not always the case (23) . The role of IL-2 in CD8 T cell immune responses has also been studied, although to only a limited extent. Superantigen-induced expansion of splenic CD8 T cells was partially impaired in IL-2 Ϫ/Ϫ mice (20) , while peptide immunization of influenza nucleoprotein-specific F5 IL-2 Ϫ/Ϫ TCR transgenic mice resulted in normal expansion of CD8 T cells (24) . With regard to the role of IL-2 in CD8 T cell responses to virus infections, only the responses to lymphocytic choriomeningitis virus and vaccinia virus infections have been studied. In one case the response to both of these infections was largely IL-2 independent (25), while in two other studies, which assessed the total increase in splenic CD8 T cell number during lymphocytic choriomeningitis virus infection, a lack of endogenous IL-2 severely inhibited the expansion of CD8 T cells (26, 27) . Regarding the contraction phase of antiviral T cell responses, cytokine deprivation has been proposed to be responsible for the loss of activated T cells (28 -30) ; therefore, cell death may be attributed to the withdrawal of growth factors such as IL-2. Recent work also suggests that IL-2 is needed to maintain memory cells (31) or, conversely, is required to regulate CD8 memory T cell levels by inducing cell death (32, 33) .
Thus, to date our knowledge of the in vivo requirement for IL-2 in the regulation of the different stages of CD8 T cell immune responses is equivocal. Also, this information is based primarily on analysis of splenic and lymph node (LN) 3 T cells, which make up only a portion of the overall immune response (34 -36) . That is, following primary activation CD8 T cells migrate to many tertiary tissues such as the lung, liver, and intestinal mucosa (35, (37) (38) (39) (40) (41) , and there is little information regarding the role of IL-2 in the control of cell expansion and death in these and other nonlymphoid tissues. Additionally, whether IL-2 encountered via autocrine or paracrine pathways may exert differential effects on T cell responses is unknown. Indeed, the fact that both sources of IL-2 may be relevant and that IL-2 can exert both growth-promoting and death-inducing effects has probably contributed to some of the present discrepancies in the literature. Thus, we set out to characterize the in vivo requirement for IL-2 at the different stages of a CD8 T cell response to a virus infection. The system used provided the means to distinguish between the effects of autocrine and paracrine IL-2 on lymphoid and nonlymphoid CD8 T cell responses. The results conclusively demonstrated that IL-2 was dispensable as a growth factor for antiviral CD8 T cells in secondary lymphoid tissues, but played an important role in augmenting the growth of CD8 T cells in nonlymphoid tissues. Intriguingly, autocrine IL-2 alone was also capable of limiting the overall magnitude of the response within nonlymphoid tissues.
Materials and Methods

Mice
C57BL/6J, C57BL/6-IL-2 Ϫ/Ϫ , and C57BL/6-CD25 Ϫ/Ϫ mice were obtained from The Jackson Laboratory (Bar Harbor, ME). C57BL/6-Ly5.2 mice were obtained from Charles River (Wilmington, MA) through the National Cancer Institute. The OT-I mouse line (42) was provided by W. R. Heath (Walter and Eliza Hall Institute, Parkville, Australia) and F. Carbone (Monash Medical School, Prahran, Australia). OT-I mice were mated to IL-2 ϩ/Ϫ mice. Offspring were screened for the IL-2 mutation by PCR, and the presence of the OT-I transgene was detected by assessing the frequency of V␣2 ϩ V␤5 ϩ CD8 ϩ cells in PBL. OT-I/IL-2 ϩ/Ϫ mice were then intercrossed to obtain OT-I/IL-2 Ϫ/Ϫ animals. OT-I/CD25 Ϫ/Ϫ animals were generated in a similar manner. OT-I-lpr/lpr mice were provided by Dr. R. Budd (University of Vermont, Burlington, VT). For in vivo proliferation assays mice were provided with water ad libitum supplemented with 0.8 mg/ml 5Ј-bromodeoxyuridine (BrdU; Sigma-Aldrich, St. Louis, MO) for 43 days as described by Tough and Sprent (43) .
Isolation of lymphocyte populations
Intraepithelial lymphocyte (IEL) and lamina propria (LP) cells from small intestine were isolated as previously described (44, 45) . Spleens and LN were removed, and single-cell suspensions were prepared using a tissue homogenizer. The resulting preparation was filtered through Nitex nylon mesh (Tetko, Kansas City, MO), and the filtrate was centrifuged to pellet the cells. To obtain lymphocytes from livers and lungs, anesthetized mice were perfused with PBS containing 75 U/ml heparin until the tissue was cleared of blood, the organs were removed, and cells were isolated as previously described (35) .
Flow cytometric analysis
Lymphocytes were resuspended in PBS/0.2% BSA/0.1% NaN 3 at a concentration of 1-10 ϫ 10 6 cells/ml, followed by incubation of 100 l of cells at 4°C for 20 min with 100 l of properly diluted mAb or at room temperature for 1 h with a PE-labeled MHC class I (H-2K b ) tetramer containing the immunodominant epitope of the nucleoprotein of vesicular stomatitis virus (VSV) (35) . mAbs specific for the following Ags and coupled to the indicated fluorochromes were used: V␤5-FITC, V␣2-PE, CD25-PE, CD44-PE, CD8-PerCP, CD8-allophycocyanin, and CD4-PE (all from BD PharMingen, San Diego, CA); CD8␣-(3.168)-FITC or -biotin (46); and Ly5.1-or Ly5.2-FITC or -Cy5 (47) . Streptavidin-PE-Cy7 (Caltag Laboratories, Burlingame, CA) was used to detect biotinylated mAb. Anti-BrdU staining was performed as described by Tough and Sprent (43) . Relative fluorescence intensities were measured with a FACSCalibur (BD Biosciences, San Jose, CA). Data were analyzed using WinMDI software (J. Trotter, Scripps Clinic, La Jolla, CA).
Adoptive transfer of OT-I, OT-I-IL-2
Ϫ/Ϫ , and OT-I-CD25 
Results
Unique roles for autocrine and paracrine IL-2 in a CD8 T cell response to a virus infection in vivo
Results obtained from previous in vivo studies using IL-2-deficient mice may have been confounded by the fact that these animals become severely immunocompromised at an early age (25) . Studies using either intact IL-2 Ϫ/Ϫ or CD25 Ϫ/Ϫ TCR transgenic mice or the adoptive transfer of T cells from these mice have also been performed. However, in these cases peptide or whole protein was the usual immunogen, and only splenic or LN responses were examined (21, 22, 24) . Therefore, we introduced the OT-I TCR transgenes (42) (V␣2 and V␤5) into IL-2-deficient or IL-2R␣ (CD25)-deficient mice for use in adoptive transfer studies in which hosts are virus-infected and multiple tissues are examined. OT-I T cells are CD8
ϩ and recognize the SIINFEKL peptide derived from chicken OVA in the context of MHC class I H-2K b . The presence of TCR transgenes delayed the onset of lymphoproliferative and inflammatory bowel disease in these mice, and all cells used for transfers were from healthy 4-to 5-wk-old animals.
We have previously shown that transfer of small numbers of OT-I cells into normal B6 mice followed by infection with a recombinant VSV containing the OVA gene (VSV-OVA) results in robust expansion of OT-I cells in lymphoid tissues as well as in intestinal LP and epithelium (39, 40) . To test the role of autocrine IL-2 in this system, trackable OT-I (Ly5.1) or OT-I-IL-2 Ϫ/Ϫ (Ly5.1) cells were transferred separately to B6-Ly5.2 hosts, which were then infected with VSV-OVA. Before immunization the transferred populations were detected in equal numbers in the blood, and each represented ϳ0.3% of lymphocytes (data not shown). Four days after infection, at the peak of the primary response, OT-I and OT-I-IL-2 Ϫ/Ϫ cells had expanded equally well in the LN and spleen (Fig. 1A , top and middle panels). In the intestinal LP significant expansion also occurred, but the increase in OT-I-IL-2 Ϫ/Ϫ cells was routinely inhibited to ϳ60% of the control values. This result suggested that autocrine IL-2 was needed for maximal CD8 T cell expansion in the LP, but not in secondary lymphoid tissues. To allow a direct comparison between wild-type and mutant OT-I cells within the same recipients we transferred equal numbers of OT-I (Ly5.1/5.2) and OT-I-IL-2 Ϫ/Ϫ (Ly5.1) cells as a mixture into naive B6-Ly5.2 recipients. Analysis of the PBL of the recipient mice before immunization confirmed an equal ratio of the two cell types (data not shown). After VSV-OVA infection, both populations expanded in roughly equal proportions in the lymphoid tissues, although there was a small, but consistent, difference between the ratio of OT-I to OT-I-IL-2 Ϫ/Ϫ cells in spleen vs LN, with the ratio in spleen always favoring OT-I-IL-2 Ϫ/Ϫ cells (Fig. 1A, bottom panels) . In striking contrast, in the intestinal LP, OT-I-IL-2 Ϫ/Ϫ cells outnumbered wild-type OT-I cells by ϳ3 to 1. The fact that OT-I-IL-2 Ϫ/Ϫ cells expanded significantly better in the presence of OT-I cells than in their absence (Fig. 1A , compare OT-I-IL-2 Ϫ/Ϫ transfer alone with transfer of the mixture in LP) suggested that paracrine IL-2 from the responding IL-2-competent OT-I cells could augment the growth of OT-I-IL-2 Ϫ/Ϫ cells in the intestinal LP. In addition, the finding that OT-I-IL-2 Ϫ/Ϫ cells outnumbered OT-I cells suggested that measured down-regulation of the CD8 T cell response occurred in the gut even as the size of the overall population increased, and that autocrine IL-2 was involved in this process.
Because IL-2 is known to regulate the expression of the IL-2R ␣-chain, CD25, the observed increase in the number of OT-I-IL-2 Ϫ/Ϫ cells in the LP may have been the result of altered CD25 levels. Naive OT-I and OT-I-IL-2 Ϫ/Ϫ cells did not express detectable levels of CD25 before (Fig. 1B, filled histograms) or after transfer. However, at 56 h postimmunization CD25 was up-regulated to similar levels on OT-I and OT-I-IL-2 Ϫ/Ϫ cells (Fig. 1B , open histograms) in the secondary lymphoid tissues. At this time point the number of donor cells in tertiary tissues is scant, making the analysis of CD25 on these cells difficult. By 81 h postimmunization marked down-regulation of CD25 expression had occurred on both donor populations in the LN, LP, and other tertiary tissues (Fig. 1B and data not shown) . At the peak of the response (ϳ96 h) CD25 was not expressed by either cell population (data not shown). Thus, the kinetics of expression of the high affinity IL-2R were similar in the presence or the absence of autocrine IL-2. At these same time points direct ex vivo IL-2 production could not be detected, but OT-I cells from all tissues produced IL-2 following short term in vitro stimulation (data not shown).
Autocrine IL-2 regulates the size of the activated CD8 T cell population in tertiary tissue
To determine whether the dysregulated growth of OT-I-IL-2 Ϫ/Ϫ cells in the LP was a general property of activated CD8 T cells in tertiary tissues, we analyzed the responses in the lung, liver, and intestinal epithelium in addition to those in LP and secondary lymphoid tissues (Fig. 2) . In the absence of immunization few naive OT-I cells are detected in intestine, lung, or liver (39, 40) (data not shown). Following VSV-OVA infection a rapid migration and continuing expansion of CD8 T cells in nonlymphoid tissues occurred (39, 40, 48, 49) (Fig. 2) . Again, both populations expanded in roughly equal proportions in the lymphoid tissues. In contrast, ϳ2.5-fold greater numbers of OT-I-IL-2 Ϫ vs wild-type OT-I cells were present in the lung, liver, and intestine (Fig. 2) , demonstrating that this phenomenon was tertiary tissue specific.
The observed difference between wild-type OT-I cells and OT-I-IL-2 Ϫ/Ϫ cells in tertiary tissues could have been due to increased proliferation, decreased apoptosis, or a combination of both during the expansion phase of the immune response. To determine whether OT-I-IL-2 Ϫ/Ϫ cells displayed increased proliferation, we labeled the mixture of donor cells with CFSE before transfer. At early time points postinfection (62 h), although there were increased numbers of OT-I-IL-2 Ϫ/Ϫ cells in the tertiary tissues, the CFSE profiles of the OT-I-IL-2 Ϫ/Ϫ cells and the OT-I control cells were identical in all tissues analyzed (Fig. 3A) , indicating that the increased numbers of OT-I-IL-2 Ϫ/Ϫ cells were not due to increased proliferation and were probably due to decreased apoptosis. By 88 h postinfection the cells in all tissues had divided extensively and had lost the CFSE label.
One mechanism by which IL-2 has been shown to regulate T cell apoptosis is via the Fas/Fas ligand pathway (9, 10, 19, 20) . Fas expression by OT-I and OT-I-IL-2 Ϫ/Ϫ cells was equivalent before and following in vivo activation (data not shown). There could, however, have been differences in the levels of intracellular signaling molecules involved in Fas-mediated apoptosis. Hence, to test whether regulation of the CD8 T cell response in tertiary tissues occurred via the Fas pathway, we transferred mixtures of (Fig.  3B, left group) . In contrast, activation of mixtures of OT-I and OT-I-lpr/lpr cells resulted in equivalent expansion of each population in all tissues (Fig. 3B, middle group) . Transfer and activation of mixtures of OT-I-lpr/lpr and OT-I-IL-2 Ϫ/Ϫ cells also resulted in disproportionate growth of OT-I-IL-2 Ϫ/Ϫ cells in the intestinal mucosa, but not in the lymphoid tissues (Fig. 3B, right group) . Therefore, the increased expansion was not due to impaired Fasmediated apoptosis. We performed similar experiments using OT-I-perforin Ϫ/Ϫ cells, since perforin has also been implicated in down-modulation of CD8 T cell responses (50 -52) . However, the ratio of wild-type to OT-I-perforin Ϫ/Ϫ cells in all tissues after infection remained ϳ1:1 (data not shown), indicating that perforin was not responsible for the observed effects. IL-2 has also been suggested to limit T cell expansion via down-regulation of intracellular Bcl-2 levels as well as the common ␥-chain, which is used by the IL-2R and other receptors for growth-promoting cytokines such as IL-7 and IL-15 (9, 53). OT-I and OT-I-IL-2 Ϫ/Ϫ cells displayed equivalent surface expression of the common ␥-chain and intracellular Bcl-2 levels before and following activation in vivo (data not shown), implying that altered levels of these molecules were not responsible for the observed phenomenon.
Requirement for IL-2 in optimal CD8 T cell expansion in tertiary tissue
It was clear from the previous experiments that although the CD8 T cells displayed impaired proliferation within tertiary tissues in the absence of autocrine IL-2 ( Fig. 1) , their expansion was still substantial. However, the experiments to date did not rule out the participation of paracrine IL-2 produced by host T cells. Thus, to determine the overall requirement for IL-2 in the antiviral OT-I response, we transferred OT-I-IL-2 Ϫ/Ϫ cells to young B6 or IL-2 Ϫ/Ϫ hosts, which were then infected with VSV-OVA, and lymphocytes were analyzed 4 days later. Consistent with the previous data, OT-I-IL-2 Ϫ/Ϫ cells proliferated in spleen and LP when transferred to B6 mice in response to viral infection. However, upon transfer and infection in IL-2 Ϫ/Ϫ mice, the response was partially inhibited in the spleen, but was inhibited to a greater extent in the LP (Fig. 4A) . This result along with that shown in Fig. 1A indicated that CD8 T cells in the LP were responding to both autocrine and paracrine IL-2 to realize optimal expansion. To corroborate the role of IL-2 in responses within tertiary tissue, we quantitated the endogenous CD8 T cell response to VSV infection in B6 or IL-2 Ϫ/Ϫ mice using MHC class I H-2K b tetramers. The splenic response after infection of young IL-2 Ϫ/Ϫ mice (which had no obvious signs of lymphoproliferative or bowel disease) was not significantly different from that of controls (Fig. 4B) . However, as in the adoptive transfer studies the response in the intestinal LP was greatly inhibited.
The results to date indicate that both autocrine and paracrine IL-2 regulate the size of the responding CD8 T cell population in tertiary tissue. To determine whether the high affinity IL-2R mediated these effects, we used OT-I-CD25
Ϫ/Ϫ cells in adoptive transfer experiments. IL-2-deficient (5) and CD25-deficient mice (4) share the same phenotype, indicating that for the most part the functions of IL-2 are conducted via signaling through the high affinity IL-2R, which includes CD25. We transferred equal numbers of OT-I (Ly5.1) and OT-I-CD25 Ϫ/Ϫ (Ly5.1/5.2) cells, either separately or as a mixture, into naive B6-Ly5.2 recipients (Fig. 5) .
Upon transfer of OT-I and OT-I-CD25
Ϫ/Ϫ cells separately (Fig. 5,  top and middle panels) , the expansion of OT-I-CD25 Ϫ/Ϫ cells was equal to that of OT-I cells in peripheral LN and was either equal to or slightly lower than (in other experiments) that in the spleen. In the tertiary tissues, however, there was a dramatic reduction in the number of OT-I-CD25
Ϫ/Ϫ cells. Identical results were obtained when a mixture of OT-I and OT-I-CD25 Ϫ/Ϫ cells (Fig. 5,  bottom panel) was transferred. Here, too, the expansion of OT-I-CD25 Ϫ/Ϫ cells was similar to that of control cells in LN, but was partially impaired in the spleen and inhibited to a greater extent in the intestinal LP (Fig. 5 ) and the liver and lung (data not shown). Notably, an increase in the number of OT-I-CD25
Ϫ/Ϫ cells in the LP and other tertiary tissues did not occur, confirming the implication that in the mixture of OT-I and OT-I-IL-2 Ϫ/Ϫ cells (Fig.  1A) , OT-I-IL-2 Ϫ/Ϫ cells were receiving paracrine IL-2, which enabled them to optimally expand. Thus, although OT-I-CD25
Ϫ/Ϫ cells in tertiary tissues may be more resistant to apoptosis due to their inability to respond to autocrine IL-2, their expansion was limited.
Autocrine IL-2 is not essential for the down-regulation of the CD8 T cell response or for maintenance of memory
The contraction phase of the T cell response has been suggested to involve IL-2 (4, 7, 20, 28 -30) . However, the kinetics of expression of CD25 (Fig. 1B) are in line with the hypothesis that IL-2 plays a role during the early expansion, but not during the contraction phase. To determine whether autocrine IL-2 was involved in the loss of activated cells after the peak of the response, we analyzed the ratio of OT-I to OT-I-IL-2 Ϫ/Ϫ cells at 7 and 16 days postimmunization when the response was declining. The proportions of wild-type and IL-2-deficient OT-I cells observed in the different tissues at the peak of the response on day 4 were maintained on days 7 and 16 during a dramatic decline in the overall number of OT-I cells (Fig. 6A) . Thus, autocrine IL-2 was important for limiting the early response, but was not involved in the overall contraction of the CD8 response. Similar results were obtained when the populations were transferred separately or when the endogenous response was measured in IL-2 Ϫ/Ϫ mice using MHC class I tetramers (data not shown).
It has been suggested that IL-2 is capable of regulating the size of the CD8 memory T cell pool (31) (32) (33) , but the source of IL-2 in this scenario is unknown. To determine whether the long term maintenance or proliferation of memory CD8 T cells was controlled by autocrine IL-2, we performed BrdU incorporation studies. Four months postimmunization mice containing OT-I or OT-I-IL-2 memory cells were fed BrdU-containing water for 43 days, and cells were isolated from various tissues and analyzed for BrdU incorporation. OT-I and OT-I-IL-2 Ϫ/Ϫ cells were detected at similar levels at this time point (day 167 postinfection). In addition, the same proportion (ϳ55%) of OT-I and OT-I-IL-2 Ϫ/Ϫ memory cells incorporated BrdU (Fig. 6B) , indicating that the turnover of memory CD8 T cells in secondary and tertiary lymphoid tissues was unaffected by the absence of autocrine IL-2. Normal percentages of endogenous memory cells were also observed in infected IL-2 Ϫ/Ϫ mice (data not shown). Thus, IL-2 was not required for antiviral memory CD8 T cell homeostasis.
Discussion
This study provided a comprehensive in vivo evaluation of the function of IL-2 in an antiviral CD8 T cell response and also revealed novel roles for IL-2 in immune response regulation. IL-2 was dispensable in the expansion and contraction phases of the CD8 T cell response in secondary lymphoid tissue. In contrast, our results revealed a heretofore unappreciated dichotomy in the role of IL-2 in regulating the growth and death of primary antiviral CD8 T cells in nonlymphoid tissues. There are limited data available on the role of IL-2 in antiviral CD8 T cell responses in vivo, and the findings are inconsistent (25) (26) (27) . The reasons for these discrepancies are unclear, but Ag-specific CD8 T cells were not rigorously quantitated in these studies. In the adoptive transfer system used here, the role of IL-2 throughout the response was monitored, and in the case of transfers of cell mixtures, a direct comparison of the response of mutant cells with that of normal cells was made.
The adoptive transfer system also allowed us to track activated CD8 T cells throughout the body. We and others have recently shown that activated T cells migrate to many nonlymphoid tissues (34 -36) . These studies show that a substantial proportion (numerically 50% or greater) of the T cell immune response is focused in nonlymphoid tissues and that functional regulation of the response is distinct between lymphoid and nonlymphoid tissues. Our present results added another dimension to these findings by demonstrating that IL-2 was involved in the regulation of nonlymphoid, but not lymphoid, CD8 T cell responses. Thus, while responding CD8 T cells in tertiary tissues were dependent on IL-2 for optimal growth at the late stage of expansion, autocrine CD8 T cell-derived IL-2 concurrently functioned as a negative regulator of the overall expansion. These results provided an interesting in vivo example of the paradoxical roles of IL-2 in T cell responses as a growth factor and as a regulator of cell death. We also demonstrated that responding CD8 T cells provided help, in the form of paracrine IL-2, to neighboring CD8 T cells. Although the most plausible explanation for the help that was provided by OT-I cells was the provision of IL-2, another possibility was that OT-I cells modified the environment in some way and indirectly aided the proliferation of OT-I-IL-2 Ϫ/Ϫ cells. The impaired proliferation of OT-I-CD25
Ϫ/Ϫ cells even in the presence of OT-I cells discounted this possibility.
We hypothesized that the observed difference between wild-type OT-I cells and OT-I-IL-2 Ϫ/Ϫ cells in tertiary tissues was probably due to increased proliferation, decreased apoptosis, or a combination of both during the expansion phase of the immune response. An alternative explanation was that an alteration occurred in the dynamics of lymphocyte homing as a consequence of OT-I development in the absence of IL-2 or in the absence of autocrine IL-2-mediated signaling. Although we have not discounted this possibility, it seems unlikely, because increased numbers of OT-I-IL-2 Ϫ/Ϫ cells were observed only when the cells were transferred along with wild-type cells and also were observed in all tertiary tissues analyzed. In addition, OT-I-CD25
Ϫ/Ϫ cells homed normally to all nonlymphoid tissues, but did not exhibit an abnormal increase in numbers at the peak of the response. The CFSE-labeling experiments demonstrated that OT-I-IL-2 Ϫ/Ϫ cells divided at the same rate as wild-type OT-I cells, ruling out increased proliferation as being the contributing factor. To date we have been unable to detect apoptotic cells during the immune response in vivo, probably due to the rapid removal of dying cells by phagocytic cells. Nevertheless, the data derived from past in vitro and in vivo studies of IL-2 function support the likelihood that IL-2 in this case was inducing cell death. Because the ability to downregulate the response was a function unique to autocrine IL-2, the question is raised of how T cells distinguish between autocrine and paracrine IL-2. The concentration of IL-2 to which the cell is exposed could be an important factor, and a cell that responds to autocrine IL-2 in addition to paracrine IL-2 might be expected to be exposed to higher cytokine concentrations. The anatomy of the tissue in which the responding CD8 T cell is located is also likely to have a significant influence, because the structure of the LN where the immune response is initiated is geared toward promotion of lymphocyte-lymphocyte interactions. In contrast, the location of lymphocyte and APC subsets in tertiary tissues such as the intestinal LP has no obvious organizational scheme. IL-2 can also be bound by the extracellular matrix (54) , which may provide a platform for interaction of T cells with cytokines, but whether there are differences in the display of IL-2 in different tissues and whether matrix-bound IL-2 plays a role in immune responses are not known.
Our hypothesis, then, is that following interaction of CD8 T cells with APC in secondary lymphoid tissue (primarily in LN), initial IL-2-independent expansion occurs, followed by rapid migration of activated CD8 T cells to tertiary tissues. In the tissues the requirement for IL-2 as a growth factor gains prominence. The cells respond to autocrine and paracrine IL-2, which support continued in situ expansion. Limiting the maximum magnitude of the response during the expansion phase is probably achieved by the induction of apoptosis in a subpopulation of responding cells, and we propose that in tertiary tissues this event is controlled by autocrine IL-2. Our results also established that in the CD8 T cell response to virus infection, the contraction of the responding population was not the result of activation-induced cell death induced by IL-2 nor was it due to deprivation of IL-2. The generation and maintenance of memory cells also were not dependent on IL-2. Overall, our results suggested mechanisms by which dysregulation of immune responses outside of the lymphoid tissue could adversely affect the outcome of the response, perhaps resulting in tissue-specific autoimmunity, such as occurs in IL-2-deficient mice. This system will allow eventual dissection of the molecular basis of IL-2-mediated control of the immune response.
